ASTERDM (Aster DM Healthcare Ltd.): Acquisition / M&A
Aster DM Healthcare Ltd has informed the Exchange about the allotment of equity shares to the shareholders of transferor company Quality Care India Limited (QCIL) pursuant to the scheme of amalgamation, according to an NSE filing dated 13 July 2026. The disclosure follows earlier announcements on 2-4 July regarding the effective date of the scheme, amended memorandum and articles of association, and the successful completion of the merger between Aster DM Healthcare and Quality Care India Limited.
Events like this—acquisition and M&A announcements—have historically shown a 48.9% win rate across 141 comparable instances, with a net edge of 0.213%, according to Strota's base rate data. This means slightly less than half of similar events have produced positive outcomes for shareholders in the past, and the historical edge is modestly positive. These figures describe the track record of the event type, not a forecast for Aster DM specifically.
The stock closed at ₹808.9 on 10 July, trading 3.3% below its 52-week high of ₹836.5 and 55.83% above its 52-week low of ₹519.1. It is currently above both its 50-day and 200-day simple moving averages. The company trades at a price-to-earnings ratio of 108.36 and a price-to-book ratio of 9.18, with a market capitalisation of ₹42,125 crore. Relative volume stands at 0.65, indicating below-average trading activity compared to recent sessions.
The filing confirms the share allotment step of the QCIL merger has been executed. What the data does not establish is whether this specific completion will move the stock price, how the integration will perform operationally, or whether the current valuation leaves room for re-rating. Investors would need to assess the merged entity's financials and management commentary separately.
The catalyst
Aster DM Healthcare Limited has informed the Exchange about allotment of equity shares to the shareholders of transferor Company (QCIL) pursuant to the scheme of Amalgamation (filing · NSE)
What the data shows after this event
Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.
ASTERDM right now
trading +0.74% on the day; P/E 108.36; RSI 61.3. Full ASTERDM analysis →
Sources
- Aster DM Healthcare Limited has informed the Exchange about allotment of equity shares to the shareholders of transferor Company (QCIL) pursuant to the scheme of Amalgamation — NSE
- Aurobindo Pharma Ltd leads losers in 'A' group — Business Standard
- How The Aster DM Healthcare (NSEI:ASTERDM) Narrative Is Shifting With New Valuation Assumptions — Simply Wall St.
- Aster DM Healthcare profit jumps 77% on strong patient growth and lab performance — CNBC TV18
- Upcoming dividends, stock splits, bonuses this week: TVS Motor Company, CRISIL, IREDA, Aster DM among others in focus — Upstox
Keep digging
- ASTERDM — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
- Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
- Newsroom: the other stocks in play this session.